Africa Patient Monitoring Devices Market Overview:
The Africa Patient Monitoring Devices Market size was valued at USD 2,046.71 MN in 2021 and reached USD 2,363.35 MN in 2025. It is anticipated to reach USD 3,080.20 MN by 2032, growing at a CAGR of 3.21% during the forecast period.
| REPORT ATTRIBUTE |
DETAILS |
| Historical Period |
2021-2024 |
| Base Year |
2025 |
| Forecast Period |
2025-2032 |
| Africa Patient Monitoring Devices Market Size 2025 |
USD 2,363.35 million |
| Africa Patient Monitoring Devices Market , CAGR |
3.21% |
| Africa Patient Monitoring Devices Market Size 2032 |
USD 3,080.20 million |
Africa Patient Monitoring Devices Market Insights
- Market growth is supported by diabetes monitoring demand, hypertension and cardiovascular disease burden, maternal and neonatal care needs, respiratory monitoring requirements and hospital modernization.
- Blood Glucose Monitoring Systems hold a strong position because diabetes diagnosis, treatment adjustment and self-monitoring require recurring use of meters, sensors, lancets, strips and connected monitoring tools.
- Multi-parameter Monitoring Devices and Cardiac Monitoring Devices remain important because hospitals and clinics need continuous patient surveillance in emergency departments, ICUs, operating rooms and specialty wards.
- Hospitals And Clinics remain the leading end-user segment because most patient monitoring requires clinical oversight, trained staff, alarm response, documentation and integration with care workflows.

Africa Patient Monitoring Devices Market Segment Insights
By product type
By product type, Blood Glucose Monitoring Systems held a strong position in 2025 because diabetes care requires frequent measurement, home monitoring and clinician review. Cardiac Monitoring Devices are supported by hypertension, stroke risk, heart failure and perioperative monitoring needs. Multi-parameter Monitoring Devices remain essential in hospitals because they combine ECG, oxygen saturation, blood pressure, respiration and temperature monitoring in critical and acute care. Respiratory Monitoring Devices are gaining relevance due to oxygen therapy, pneumonia, neonatal care and emergency medicine. Temperature Monitoring Devices support infection screening, perioperative care and inpatient monitoring. Hemodynamic/Pressure Monitoring Devices support ICU care and surgery. Fetal & Neonatal Monitoring Devices address maternal and newborn health needs. Neuromonitoring Devices, Weight Monitoring Devices and Others support specialty care, chronic disease tracking and connected monitoring.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
Download Sample
By end-user
By end-user, Hospitals And Clinics held the strongest position in 2025 because inpatient wards, operating rooms, emergency departments, ICUs, maternity units and neonatal units require continuous monitoring infrastructure. Ambulatory Surgical Centers generate demand for vital sign monitors, cardiac monitors, respiratory monitors and temperature monitoring devices during perioperative care. Homecare is expanding as chronic disease management, diabetes care, post-discharge follow-up and remote monitoring shift closer to patients. Others include long-term care facilities, emergency medical services, diagnostic centers, telehealth providers and community health programs. Growth will depend on equipment affordability, training, service support, consumables availability, reimbursement and digital connectivity.
Key Market Drivers
Diabetes burden and glucose monitoring demand
Diabetes burden and glucose monitoring demand represent major growth drivers for the Africa Patient Monitoring Devices Market. WHO reported that an estimated 54 million adults aged 18 and above had diabetes in the WHO African Region in 2022, with more than half undiagnosed and untreated. WHO also reported in 2025 that more than 24 million adults aged 20 to 79 were living with diabetes in the African Region, reinforcing the need for equitable and comprehensive diabetes care. This driver supports Blood Glucose Monitoring Systems, Homecare, Hospitals And Clinics and Specialty monitoring pathways. Growth will depend on screening coverage, meter affordability, strip availability, primary care integration and patient education.
Hypertension and cardiovascular monitoring needs
Hypertension and cardiovascular monitoring needs are strengthening demand for cardiac monitors, blood pressure devices, multi-parameter monitors and home-based monitoring. WHO’s 2025 global hypertension report highlights the urgent need to scale up detection, treatment and control of high blood pressure, especially at the primary health care level. WHO Africa also states that drug treatment of diabetes, hypertension and high blood lipids may be necessary to reduce cardiovascular risk and prevent heart attacks and strokes.
Respiratory monitoring and oxygen access priorities
Respiratory monitoring and oxygen access priorities support demand for pulse oximeters, respiratory monitors, multi-parameter monitors and hospital monitoring systems. WHO states that all levels of the health system require oxygen and pulse oximeters to monitor oxygen saturation in patients. WHO also identifies pulse oximetry as the most accurate non-invasive method for detecting hypoxaemia and calls a pulse oximeter an essential medical device for monitoring and patient safety.
Maternal and neonatal monitoring demand
Maternal and neonatal monitoring demand supports fetal monitors, neonatal monitors, temperature monitoring devices, respiratory monitoring and multi-parameter systems. WHO Africa reported that although stillbirth and neonatal mortality rates declined between 2000 and 2023, sub-Saharan Africa still accounted for 47% of stillbirths and 46% of global newborn deaths. This clinical burden supports Fetal & Neonatal Monitoring Devices, Temperature Monitoring Devices, Respiratory Monitoring Devices and Hospitals And Clinics. Demand will rise as maternity units, neonatal intensive care units and referral hospitals invest in monitoring equipment, trained staff and neonatal emergency care.
Hospital monitoring modernization and connected care platforms
Hospital monitoring modernization and connected care platforms are improving demand for multi-parameter monitors, central stations, mobile monitors and clinical information systems. GE HealthCare’s 2025 annual filing said its patient monitoring portfolio ranges from spot-check to continuous monitoring and includes comprehensive multi-parameter monitors, central stations, wearable and mobile monitors, transport monitors, cardiac telemetry and care team collaboration solutions. Philips’ 2025 annual filing described Connected Care as including hospital patient monitoring, ambulatory monitoring, enterprise informatics and sleep and respiratory care.
Key Trends and Opportunities
Homecare monitoring expands chronic disease management
Homecare monitoring is expanding as diabetes, hypertension, obesity, heart disease and respiratory conditions require frequent tracking outside hospitals. Blood Glucose Monitoring Systems, Weight Monitoring Devices, Cardiac Monitoring Devices and Respiratory Monitoring Devices can support early warning, patient self-management and remote clinician review. WHO’s diabetes technology report highlights the importance of availability and affordability of blood glucose meters, test strips, lancets, blood pressure measurement devices and glycated haemoglobin analysers for diabetes management. Homecare growth will depend on affordability, patient education, mobile connectivity, consumable supply and primary care follow-up.
Multi-parameter monitors become central to hospital capacity
Multi-parameter monitors are becoming central to hospital capacity because ICUs, emergency departments, operating rooms and inpatient wards need continuous monitoring of ECG, oxygen saturation, blood pressure, respiration and temperature. These systems reduce the need for separate single-parameter equipment and support faster clinical response. GE HealthCare reported that its Patient Monitoring business includes proprietary parameters, complementary consumables and OEM parameters integrated into its monitoring fleet, creating recurring revenue streams.
Neonatal and obstetric monitoring gains policy relevance
Neonatal and obstetric monitoring is gaining policy relevance because maternal and newborn survival remains a high-priority health objective across Africa. Fetal & Neonatal Monitoring Devices, respiratory monitors, temperature monitors and multi-parameter monitors are needed in maternity wards, delivery rooms and neonatal units. WHO Africa’s 2025 maternal and newborn mortality update underlines slow progress and the need for stronger investment in maternal and newborn health. Vendors with rugged devices, battery backup, training programs and local service support can gain stronger adoption in public hospitals and referral centers.
Connected monitoring and telemetry improve workflow
Connected monitoring and telemetry are improving clinical workflow by allowing care teams to view patient status across wards, step-down units and mobile care settings. Dräger’s 2025 annual report said the company launched the Dräger Vista T100, a portable telemetry monitor for reliable continuous monitoring of mobile patients, and expanded the functions of its Infinity Acute Care System patient monitoring platform. This trend supports Cardiac Monitoring Devices, Multi-parameter Monitoring Devices, Respiratory Monitoring Devices and hospital digitalization. Adoption will depend on network infrastructure, training, cybersecurity and service reliability.
Key Market Challenges
Affordability and procurement constraints
Affordability and procurement constraints remain major challenges for the Africa Patient Monitoring Devices Market. Patient monitors, telemetry systems, neonatal monitors, glucose monitoring supplies and respiratory monitoring devices require upfront capital, recurring consumables, maintenance and staff training. Public hospitals may face delayed tenders and budget pressure, while smaller clinics may prioritize basic devices over connected monitoring platforms. Homecare adoption can also be limited when patients must pay for glucose strips, batteries, sensors and device replacements. Vendors must offer value-tier systems, financing models, local service and reliable consumable supply.
Limited biomedical engineering and maintenance capacity
Limited biomedical engineering and maintenance capacity can restrict equipment uptime. Patient monitoring systems require installation, calibration, software updates, spare parts and preventive maintenance. When service networks are weak, hospitals may have installed monitors that are underused or out of service. This challenge is especially relevant outside major cities, where technical support and replacement parts may be limited. Manufacturers and distributors must build local engineer networks, training programs, spare-parts inventory and preventive maintenance contracts.
Workforce training and alarm response gaps
Workforce training and alarm response gaps affect patient safety and device utilization. Monitoring devices generate continuous data, alarms and clinical signals that require trained nurses, physicians and technicians. Poor alarm management can create fatigue, while insufficient training can lead to missed deterioration, incorrect readings or inconsistent documentation. Hospitals and clinics need standard protocols for glucose monitoring, ECG monitoring, pulse oximetry, neonatal monitoring and multi-parameter surveillance. Suppliers that provide clinical education, onboarding and workflow support will improve adoption.
Connectivity and data integration limitations
Connectivity and data integration limitations slow adoption of advanced patient monitoring platforms. Central monitoring, telemetry, remote monitoring and digital dashboards require reliable networks, cybersecurity controls, health information systems and interoperability. Many facilities still operate with fragmented records and limited IT support. These constraints affect Multi-parameter Monitoring Devices, Cardiac Monitoring Devices, Homecare and connected hospital platforms. Adoption will depend on digital infrastructure, vendor integration support, training and hospital investment in informatics.
Regional Analysis
South Africa
South Africa leads the Africa Patient Monitoring Devices Market due to stronger hospital infrastructure, private health care investment, specialist capacity and broader access to advanced monitoring equipment. Hospitals And Clinics dominate demand for multi-parameter monitors, cardiac monitors, respiratory monitoring devices, fetal and neonatal monitors and glucose monitoring systems. Homecare is gaining relevance through chronic disease monitoring and post-discharge care. Growth will depend on private hospital upgrades, public procurement, diabetes care, ICU capacity, device replacement cycles and service availability.
Egypt
Egypt represents a major growth market due to its large population, public hospital network, private hospital expansion and rising chronic disease burden. Blood Glucose Monitoring Systems, Cardiac Monitoring Devices, Multi-parameter Monitoring Devices and Respiratory Monitoring Devices are key demand areas. Hospitals And Clinics remain the leading end users, while Homecare has long-term potential through diabetes and hypertension monitoring. Growth will depend on public procurement, distributor reach, affordability, physician adoption, consumable availability and device maintenance.
Nigeria
Nigeria offers long-term growth potential due to large unmet monitoring needs, diabetes and hypertension burden, neonatal care needs and private hospital expansion. Demand is strongest in urban hospitals and clinics, where multi-parameter monitors, cardiac monitors and respiratory monitoring devices support acute care and surgical capacity. Homecare adoption is growing slowly due to affordability barriers and uneven access to connected health services. Growth will depend on insurance expansion, public-private partnerships, primary care strengthening and biomedical engineering support.
Kenya
Kenya is an emerging market supported by referral hospitals, private health care investment, maternal and newborn health programs and chronic disease monitoring needs. Hospitals And Clinics generate demand for multi-parameter monitors, fetal and neonatal monitors, blood glucose monitoring systems and respiratory monitoring devices. Homecare can expand through diabetes, blood pressure and post-discharge monitoring. Growth will depend on county-level investment, equipment financing, technical support, clinician training and digital health integration.
Rest of Africa
Rest of Africa includes markets with varied hospital infrastructure, monitoring access, procurement capacity and service coverage. Countries with stronger tertiary hospitals and private health systems will adopt connected monitoring faster, while lower-resource settings will prioritize essential monitoring such as pulse oximetry, blood glucose meters, blood pressure monitors, thermometers and basic multi-parameter monitors. WHO’s oxygen guidance emphasizes that all health system levels require oxygen and pulse oximeters, reinforcing the importance of essential monitoring access. Long-term growth will depend on donor support, national procurement, workforce training, local distribution and maintenance capacity.
Report Attribute Details
| Report Attribute |
Details |
| Historical Period |
2021–2024 |
| Base Year |
2025 |
| Forecast Period |
2025–2032 |
| Market Size in 2021 |
USD 2,046.71 MN |
| Market Size in 2025 |
USD 2,363.35 MN |
| Market Size in 2032 |
USD 3,080.20 MN |
| CAGR |
3.21% |
| Segments Covered |
Product Type, End-User and Geography |
| Key Companies Covered |
NemoCare Wellness, Narang Medical, Medtronic plc, GE Healthcare, Philips Healthcare, Nihon Kohden Corporation, Abbott Laboratories, Minday Medical International Ltd, Drägerwerk AG & Co. KGaA, Welch Allyn and Natus Medical |
Africa Patient Monitoring Devices Market Segmentations
By Product Type
- Blood Glucose Monitoring Systems
- Cardiac Monitoring Devices
- Multi-parameter Monitoring Devices
- Respiratory Monitoring Devices
- Temperature Monitoring Devices
- Hemodynamic/Pressure Monitoring Devices
- Fetal & Neonatal Monitoring Devices
- Neuromonitoring Devices
- Weight Monitoring Devices
- Others
By End-User
- Hospitals And Clinics
- Ambulatory Surgical Centers
- Homecare
- Others
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
Key players
- NemoCare Wellness
- Narang Medical
- Medtronic plc
- GE Healthcare
- Philips Healthcare
- Nihon Kohden Corporation
- Abbott Laboratories
- Minday Medical International Ltd
- Drägerwerk AG & Co. KGaA
- Welch Allyn
- Natus Medical
Recent Developments
- In 2025, Abbott reported that sales of its continuous glucose monitoring systems totaled USD 7.6 billion, compared with USD 6.4 billion in 2024, supporting growth in connected glucose monitoring.
- In 2025, GE HealthCare reported that its patient monitoring portfolio includes spot-check, continuous, multi-parameter, central station, wearable, mobile, transport and cardiac telemetry monitoring solutions.
- In 2025, Philips reported that Connected Care includes hospital patient monitoring, ambulatory monitoring, enterprise informatics and sleep and respiratory care.
- In 2025, Dräger launched the Dräger Vista T100 portable telemetry monitor and expanded the functions of its Infinity Acute Care System patient monitoring platform.
- In FY2025, Nihon Kohden reported that its patient monitor category includes central monitors, bedside monitors, wireless monitors, remote access software, clinical information systems and related consumables such as electrodes and sensors.
Report Coverage
The research report offers an in-depth analysis based on product type, end-user and geography. It details leading market players, providing an overview of their business positioning, patient monitoring device portfolios, blood glucose monitoring systems, cardiac monitoring devices, multi-parameter monitors, respiratory monitoring devices, temperature monitors, hemodynamic monitoring systems, fetal and neonatal monitors, neuromonitoring systems, weight monitoring devices, connected monitoring platforms and strategic relevance in the Africa Patient Monitoring Devices Market. The report includes insights into the competitive environment, market trends, growth drivers, restraints and opportunities. It also examines diabetes burden, hypertension care, oxygen and respiratory monitoring, neonatal survival needs, hospital modernization, homecare monitoring, telemetry adoption, equipment maintenance and workforce training as major factors shaping market development. The report assesses the impact of affordability constraints, procurement delays, limited biomedical engineering capacity, alarm response gaps, connectivity limitations and consumable availability on market growth. It provides strategic recommendations for patient monitoring device manufacturers, hospitals, clinics, ASCs, homecare providers, distributors, procurement agencies, investors and new entrants seeking to navigate Africa’s patient monitoring device ecosystem.
Future Outlook
- Demand for patient monitoring devices will continue to rise as African health systems expand chronic disease care, emergency monitoring and hospital capacity.
- Blood Glucose Monitoring Systems will remain a major product category due to diabetes burden and the need for regular self-monitoring.
- Cardiac Monitoring Devices will gain demand through hypertension, cardiovascular risk tracking, ICU care and perioperative monitoring.
- Multi-parameter Monitoring Devices will remain essential in ICUs, emergency departments, operating rooms and inpatient wards.
- Respiratory Monitoring Devices will grow through oxygen access programs, pneumonia care, critical care and neonatal respiratory support.
- Fetal & Neonatal Monitoring Devices will gain importance as countries strengthen maternal and newborn care.
- Homecare will expand gradually as patients use monitoring devices for diabetes, blood pressure, weight and post-discharge follow-up.
- Hospitals And Clinics will remain the leading end-user segment due to patient acuity, procedure volume and clinical oversight needs.
- Connected monitoring, telemetry and central stations will gain adoption in advanced hospitals and private networks.
- Competition will increase as companies compete on affordability, accuracy, durability, battery life, consumable availability, service support and connectivity.